Daxor Corporation (DXR) Stock

NASDAQ: DXRDevelops and markets biotechnology instrumentation for blood volume analysis.

Daxor stock price chart

DXR stock quote & key statistics

Daxor earnings per share

Income →
Earnings per share

Daxor revenue & net income

Income →
RevenueNet income

Daxor annual financials

Income statement →
Daxor Corporation revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$503,424$9.2M—
FY2024$2.1M$536,334$0.43
FY2023$34.6M$280,640$0.00
FY2022$6.3M$5.2M$1.09
FY2021$5.8M$4.7M$0.99

Fiscal year ending December 31. Source: company filings via EODHD.

About Daxor Corporation

Daxor Corporation, based in Oak Ridge, Tennessee, is a leading medical device company specializing in blood volume measurement technology. At the heart of its offerings is the BVA-100 Blood Volume Analyzer, a cutting-edge diagnostic tool that provides precise, objective quantification of blood volume status and composition. This innovative technology helps healthcare professionals assess and manage patients' blood volume in various medical and surgical settings, ensuring tailored treatment plans aligned with individual patient needs.

Originally known as Idant Corporation, Daxor Corporation underwent a name change in May 1973 to reflect its focus on advancing medical diagnostics through innovative solutions. Since its incorporation in 1971, the company has been dedicated to enhancing healthcare outcomes through accurate blood volume testing. By providing clinicians with reliable data compared to patient-specific norms, Daxor Corporation supports informed clinical decisions and improves patient care across diverse healthcare environments.

Daxor Corporation continues to drive innovation in blood volume measurement, leveraging decades of expertise and ongoing research to expand its technology's applications. With a commitment to advancing medical diagnostics, the company remains at the forefront of delivering reliable solutions that empower healthcare providers worldwide.

Daxor stock FAQ

What is the Daxor stock ticker symbol?

Daxor Corporation trades on the NASDAQ under the ticker symbol DXR.

What sector and industry is Daxor in?

Daxor Corporation is classified in the Healthcare sector, Medical Instruments & Supplies industry.

What were Daxor's revenue and earnings last fiscal year?

Daxor reported revenue of $503,424 and net income of $9.2M in fiscal 2025. Revenue declined 76.4% from the prior year.

When did Daxor go public?

Daxor stock began trading on March 17, 1992.

Medical Instruments & Supplies stocks

All Healthcare stocks →